← Back to Search

Tele-Taking Charge for Stroke (TeleTaCAS Trial)

N/A
Waitlist Available
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks after receiving tele-tacas
Awards & highlights

TeleTaCAS Trial Summary

This trial will evaluate a novel, community-based treatment for stroke (Take Charge) to see if it is feasible & acceptable to deliver by telehealth, potentially improving access for people in rural areas.

Eligible Conditions
  • Stroke

TeleTaCAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks after receiving tele-tacas
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks after receiving tele-tacas for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of recruitment
Secondary outcome measures
Acceptability of Tele-TaCAS
Activities of Daily Living - Barthel Index
Eligibility
+6 more

TeleTaCAS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-TaCASExperimental Treatment1 Intervention
Two Take Charge sessions delivered by telehealth six weeks apart, the first being at 2 to 16 weeks after stroke, the earliest possible time after discharge to the community.
Group II: ControlActive Control1 Intervention
Life After Stroke: Survivor Stories video played by telehealth at 2 to 16 weeks after stroke, the earliest possible time after discharge to the community.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
780 Previous Clinical Trials
841,584 Total Patients Enrolled
29 Trials studying Stroke
14,136 Patients Enrolled for Stroke

Media Library

Take Charge Clinical Trial Eligibility Overview. Trial Name: NCT05588947 — N/A
Stroke Research Study Groups: Tele-TaCAS, Control
Stroke Clinical Trial 2023: Take Charge Highlights & Side Effects. Trial Name: NCT05588947 — N/A
Take Charge 2023 Treatment Timeline for Medical Study. Trial Name: NCT05588947 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still open for this medical experiment?

"According to clinicaltrials.gov, this particular medical experiment is no longer actively recruiting patients as it was last edited on October 17th 2022. Despite the disparity in availability, there are still 1043 other studies out there looking for volunteers at present."

Answered by AI
~62 spots leftby Mar 2025